Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Duodecim; Laaketieteellinen Aikakauskirja|June 2, 2016
[Immuno-oncology--silver bullets or mass destruction weapons?]Meri Utriainen, Mika Rämet
Surgical Oncology|October 10, 2025
Postoperative complications and their risk factors in breast cancer patients treated with neoadjuvant chemotherapyOlga Kähkönen, Harri Mustonen, Meri Utriainen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|July 6, 2010
[Long-term morbidity caused by breast cancer therapy]Marjut Leidenius, Tiina Tasmuth, Tiina Jahkola, et al.
Journal of Cancer Research and Clinical Oncology|May 13, 2023
Characterization of clinicopathological features, treatment practices, and outcomes among Finnish advanced breast cancer patients in real-life clinical practiceKrista Heinolainen, Silva Saarinen, Simona Vertuani, et al.
Breast Cancer Research and Treatment|April 1, 2024
Long-term effects of aromatase inhibitor withdrawal on bone mineral density in early breast cancer patients: 10-year follow-up results of the BREX studyCarl Blomqvist, Leena Vehmanen, Pirkko-Liisa Kellokumpu-Lehtinen, et al.
In Vivo (Athens, Greece)|April 28, 2019
Effectiveness of a 12-month Exercise Intervention on Physical Activity and Quality of Life of Breast Cancer Survivors; Five-year Results of the BREX-studyHeidi Penttinen, Meri Utriainen, Pirkko-Liisa Kellokumpu-Lehtinen, et al.
In Vivo (Athens, Greece)|March 1, 2020
Health-related Quality of Life of Breast Cancer Survivors Attending an Exercise Intervention Study: A Five-year Follow-upEija Roine, Harri Sintonen, Pirkko-Liisa Kellokumpu-Lehtinen, et al.
Acta Oncologica (Stockholm, Sweden)|July 26, 2022
Factors predicting long-term physical activity of breast cancer survivors. 5-year-follow-up of the BREX exercise intervention studyKristiina Kokkonen, Pirkko-Liisa Kellokumpu-Lehtinen, Markku Kankaanpää, et al.
Pageof 2